NCT00198029View on ClinicalTrials.gov

An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Carpometacarpal Osteoarthritis
Interventions
DEVICE

Synvisc (hylan G-F20)

32 subjects in the pilot study have received 3 1ml injections of Synvisc intraarticular over the course of 3 weeks and then followed for 6 months post injection

Trial Locations (1)

10021

Hospital for Special Surgery, New York

All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

lead

Hospital for Special Surgery, New York

OTHER

NCT00198029 - An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study | Biotech Hunter | Biotech Hunter